Wells Fargo starts coverage of Progyny stock with a USD 37.00 target

Published on 10/06/2026 at 03:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 350.51 million, up 5.30 percent year over year. Progyny stock was USD 25.86 on Nasdaq after USD 25.23.

PGNY, US74340E1038, Illustration mit AI erstellt.

Progyny (ISIN US74340E1038) received a new analyst benchmark on September 30, 2026, when Wells Fargo initiated coverage with an Overweight rating and a USD 37.00 price target, according to MarketBeat. The target places the research view above the Nasdaq share price cited later in this article and makes analyst expectations the central valuation reference.

Wells Fargo sets a new benchmark

The September 30, 2026 report adds a USD 37.00 target to a range of published views on Progyny. According to MarketBeat on September 8, 2026, Citizens JMP raised its target from USD 31.00 to USD 33.00 while maintaining a Market Outperform rating. That sequence shows a higher target from Wells Fargo than the earlier Citizens JMP view, but the ratings are not identical and should be read separately.

Second-quarter earnings beat estimates

Progyny reported USD 350.51 million in revenue for the second quarter of 2026, up 5.30 percent from the same quarter a year earlier. The company also reported earnings per share of USD 0.55, compared with a USD 0.33 consensus estimate, according to MarketBeat. The USD 0.22 difference between reported and consensus earnings per share is the clearest quantified support for the positive analyst stance, while the revenue growth rate points to more moderate expansion.

Management guidance cited by MarketBeat calls for third-quarter 2026 earnings per share of USD 0.50 to USD 0.52 and full-year 2026 earnings per share of USD 2.04 to USD 2.10. Those ranges give investors a near-term operating yardstick alongside the longer-term analyst targets.

Nasdaq price remains below yearly high

On Nasdaq, Progyny was trading at USD 25.86 on October 5, 2026 at 4:00 p.m. ET, versus a prior close of USD 25.23. The market capitalization was USD 2.0 billion, while the 52-week range stood at USD 16.10 to USD 33.07 on the same quote date. The share price therefore sits below the yearly high, leaving the USD 37.00 Wells Fargo target as a separate research scenario rather than a realized market level.